Gilead Sciences Breaks Ground on New Biomanufacturing Hub

Gilead Breaks Ground on Technical Development Hub to Drive US Biopharma Innovation

The new 180,000-square-foot facility in Foster City anchors the company’s long-term $32 billion investment in domestic manufacturing and R&D.

Gilead Sciences Breaks Ground on New Biomanufacturing Hub

Gilead Sciences broke ground on its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the company’s Foster City headquarters in California. This milestone marks continued momentum in Gilead’s multi-year strategy to drive growth and scientific leadership across virology, oncology, and inflammation, increasingly built on growing biologics capabilities, according to Daniel O’Day, chairman and CEO. “This n…

Gilead Sciences Announces Groundbreaking on 180,000 SQFT Pharmaceutical Development Facility in Foster City - The Registry

New Bay Area Building Marks Significant Progress as Part of $32 Billion U.S. Investment Projected to Create $43 Billion in Economic Value FOSTER CITY, Calif.– Gilead Sciences (Nasdaq: GILD) today celebrates the groundbreaking of its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the company’s Foster City headquarters. This milestone marks continued […] The post Gilead Sciences Announces Groundbreaki…